Fernwood Investment Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-38,547
| Closed | -$5.25M | – | 189 |
|
|
2020
Q3 | $5.25M | Sell |
38,547
-1,350
| -3% | -$144K | 2.48% | 10 |
|
|
2020
Q2 | $3.85M | Sell |
39,897
-31,339
| -44% | -$2.61M | 1.91% | 10 |
|
|
2020
Q1 | $3.34M | Sell |
71,236
-8,772
| -11% | -$562K | 2.13% | 6 |
|
|
2019
Q4 | $5.83M | Sell |
80,008
-28,845
| -26% | -$1.75M | 2.79% | 4 |
|
|
2019
Q3 | $5.68M | Sell |
108,853
-11,395
| -9% | -$606K | 2.81% | 4 |
|
|
2019
Q2 | $6.03M | Sell |
120,248
-545
| -0.5% | -$26.5K | 3.3% | 3 |
|
|
2019
Q1 | $6.28M | Sell |
120,793
-20,718
| -15% | -$954K | 3.35% | 3 |
|
|
2018
Q4 | $6.91M | Sell |
141,511
-11,620
| -8% | -$640K | 4.46% | 2 |
|
|
2018
Q3 | $9.98M | Sell |
153,131
-51,919
| -25% | -$3.05M | 5.28% | 2 |
|
|
2018
Q2 | $10.2M | Sell |
205,050
-74,623
| -27% | -$3.61M | 5.5% | 2 |
|
|
2018
Q1 | $13.6M | Buy |
279,673
+15,219
| +6% | +$791K | 7.61% | 2 |
|
|
2017
Q4 | $11.1M | Buy |
264,454
+18,072
| +7% | +$696K | 5.95% | 2 |
|
|
2017
Q3 | $10.6M | Buy |
246,382
+197,989
| +409% | +$6.32M | 6.61% | 3 |
|
|
2017
Q2 | $634K | Buy |
48,393
+5,070
| +12% | +$66.8K | 0.46% | 61 |
|
|
2017
Q1 | $570K | Buy |
43,323
+327
| +0.8% | +$4.19K | 0.45% | 60 |
|
|
2016
Q4 | $557K | Buy |
42,996
+10,996
| +34% | +$169K | 0.53% | 56 |
|
|
2016
Q3 | $523K | Buy |
32,000
+4,000
| +14% | +$72.2K | 0.48% | 63 |
|
|
2016
Q2 | $347K | Hold |
28,000
| – | – | 0.34% | 78 |
|
|
2016
Q1 | $300K | Sell |
28,000
-2,000
| -7% | -$18.2K | 0.3% | 82 |
|
|
2015
Q4 | $440K | Buy |
+30,000
| New | +$367K | 0.38% | 66 |
|
Fernwood Investment Management's MYOK Position: Q4 2020 in Review
Fernwood Investment Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 38,547 shares — an estimated $5.25M sold.
Fernwood Investment Management first reported a position in MYOK in Q4 2015 and held it in 20 quarters. The position peaked at $13.6M in Q1 2018. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Fernwood Investment Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Fernwood Investment Management sold 38,547 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $5.25M.
- Fernwood Investment Management first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 20 quarters.
- Fernwood Investment Management's MyoKardia, Inc. Common Stock position peaked at $13.6M in Q1 2018.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Fernwood Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.